Topics

Treating Post-Lyme Disease Syndrome With Acetogenins

2019-09-11 01:53:33 | BioPortfolio

Summary

To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS).

Description

To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS). After failure of antibiotic therapy to relive persistent symptoms of Lyme Disease, the use of Acetogenins to elevate Post-Lyme Disease Syndrome.

Study Design

Conditions

Post-Lyme Disease Syndrome (PLDS)

Intervention

ReaLife+ (RLP), Inert Brown powder

Location

Optimal Health Research
Salt Lake City
Utah
United States
84117

Status

Active, not recruiting

Source

Optimal Health Research

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-09-11T01:53:33-0400

Clinical Trials [1950 Associated Clinical Trials listed on BioPortfolio]

Study and Treatment of Post Lyme Disease (STOP-LD)

The purpose of this study is to see how well antibiotics work in reducing chronic fatigue symptoms, such as tiredness, in patients that were treated for Lyme Disease. Fatigue is a common s...

Disulfiram: A Test of Symptom Reduction Among Patients With Previously Treated Lyme Disease

Approximately 10-20% of patients experience ongoing symptoms despite having received standard antibiotic therapy for Lyme disease. Possible explanations for persistent symptoms include per...

Patient's Pretreatment Expectations About Post-Lyme Symptoms

The investigators will focus on pretreatment expectations of patients with early Lyme disease manifested as erythema migrans with the aim of assessing the association between pretreatment ...

Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes

Hypothesis: Does treatment of lower extremity clothing with permethrin prevent Lyme disease? This is a double-blind, randomized clinical trial using permethrin treatment of clothing to pr...

Efficacy of a Brown Seaweed Powder for Glycemic Control

The objectives of this trial are to confirm efficacy in human of a brown seaweed powder and explore dose-response relationship by comparing two different doses. The primary endpoint is in...

PubMed Articles [24399 Associated PubMed Articles listed on BioPortfolio]

Association of small fiber neuropathy and post treatment Lyme disease syndrome.

To examine whether post-treatment Lyme disease syndrome (PTLDS) defined by fatigue, cognitive complaints and widespread pain following the treatment of Lyme disease is associated with small fiber neur...

Stationary phase persister/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and treatment failure.

Although most patients with Lyme disease can be cured with a 2-4 week antibiotic therapy, about 10-20% of patients continue to suffer prolonged persistent symptoms, a condition called post-treatment L...

Postoperative Lyme Arthritis in the Orthopaedic Patient.

Lyme disease is the most common tick-borne illness in North America and Europe, and Lyme arthritis is a frequent late-stage manifestation in the United States. However, Lyme arthritis has rarely been ...

Is it possible to Make a Correct Diagnosis of Lyme Disease on Symptoms Alone? Review of Key Issues and Public Health Implications.

There is much confusion and misinformation about the diagnosis of Lyme disease, as well as its treatment. This review explains why one cannot make a correct diagnosis of Lyme disease based on diagnosi...

Lyme Arthritis in a Military Dependent Child transferred from Japan.

Lyme arthritis is the most common manifestation of late Lyme disease in children. Lyme disease is known to be endemic to Japan, but is rarely diagnosed. We report the identification and successful tre...

Medical and Biotech [MESH] Definitions

An infectious disease caused by a spirochete, BORRELIA BURGDORFERI, which is transmitted chiefly by Ixodes dammini (see IXODES) and pacificus ticks in the United States and Ixodes ricinis (see IXODES) in Europe. It is a disease with early and late cutaneous manifestations plus involvement of the nervous system, heart, eye, and joints in variable combinations. The disease was formerly known as Lyme arthritis and first discovered at Old Lyme, Connecticut.

Vaccines or candidate vaccines used to prevent LYME DISEASE.

Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

An unexplained illness which is characterized by skin manifestations including non-healing lesions, itching, and the appearance of fibers. There appears to be a strong association with LYME DISEASE.

The organic and psychogenic disturbances observed after closed head injuries (HEAD INJURIES, CLOSED). Post-concussion syndrome includes subjective physical complaints (i.e. headache, dizziness), cognitive, emotional, and behavioral changes. These disturbances can be chronic, permanent, or late emerging.

More From BioPortfolio on "Treating Post-Lyme Disease Syndrome With Acetogenins"

Quick Search

Searches Linking to this Trial